CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP & Chief Financial Officer sold 3,500 shares at $22.24 ($77,835)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale President & CEO sold 7,602 shares at an average $28.11 ($213,662)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $24.97 ($187,300)
- 4 Open-market sale EVP & Chief Scientific Officer sold 16,175 shares at an average $28.80 ($465,770)
- 4 Open-market sale EVP & Chief Medical Officer sold 3,995 shares at $30.17 ($120,512)
- 4 Open-market sale EVP & Chief Financial Officer sold 5,000 shares at an average $28.44 ($142,176)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 27 · 524 filings